Entering the mainstream of cancer treatment

By November 2004, when the first issue of Nature Reviews Clinical Oncology was published, cancer immunotherapy had been successfully applied to the treatment of selected human cancers; however, dramatic progress in the following decade has moved immunotherapy from the sidelines of cancer treatment i...

Full description

Saved in:
Bibliographic Details
Published inNature reviews. Clinical oncology Vol. 11; no. 11; pp. 630 - 632
Main Author Rosenberg, Steven A.
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.11.2014
Nature Publishing Group
Subjects
692/308/2779
692/699/67/1059/2325
692/699/67/1059/602
Cancer
Care and treatment
Immunotherapy
Medicine & Public Health
Methods
news-and-views
Oncology
Online AccessGet full text

Cover

More Information
Summary:By November 2004, when the first issue of Nature Reviews Clinical Oncology was published, cancer immunotherapy had been successfully applied to the treatment of selected human cancers; however, dramatic progress in the following decade has moved immunotherapy from the sidelines of cancer treatment into the mainstream of modern oncology.
ISSN:1759-4774
1759-4782
DOI:10.1038/nrclinonc.2014.174